Cellebrite DI (CLBT) Non-Current Deffered Revenue (2020 - 2025)

Cellebrite DI's Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $49.5 million for Q4 2025.

• On a quarterly basis, Non-Current Deffered Revenue rose 9.46% year-over-year to $49.5 million in Q4 2025; TTM through Dec 2025 was $49.5 million, a 9.46% increase from a year earlier, with the FY2025 full-year figure at $49.5 million, up 9.46% from the prior year.
• Non-Current Deffered Revenue advanced to $49.5 million in Q4 2025 per CLBT's latest filing, from $45.2 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $49.5 million in Q4 2025 and bottomed at $34.4 million in Q3 2021.
• The 5-year median for Non-Current Deffered Revenue is $43.7 million (2022), against an average of $42.5 million.
• Across the five-year window, Non-Current Deffered Revenue increased 15.78% in 2022 and slipped 3.93% in 2024, its largest moves.
• Year by year, Non-Current Deffered Revenue stood at $36.4 million in 2021, then advanced by 15.78% to $42.2 million in 2022, then rose by 11.68% to $47.1 million in 2023, then dropped by 3.93% to $45.2 million in 2024, then increased by 9.46% to $49.5 million in 2025.
• Per Business Quant, the three latest CLBT Non-Current Deffered Revenue figures stand at $49.5 million (Q4 2025), $45.2 million (Q4 2024), and $47.1 million (Q4 2023).